3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Neoplasms
1
Testicular Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
48
enzalutamide
46
apalutamide
36
Specimen Handling
31
Androgen Antagonists
30
Abiraterone Acetate
29
Radiosurgery
26
Prednisone
26
darolutamide
25
Docetaxel
25
Pluvicto
21
abiraterone
19
Radiotherapy
19
Biopsy
17
Leuprolide
15
Surveys and Questionnaires
11
Radiation
11
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
11
relugolix
10
gallium 68 PSMA-11
10
cabazitaxel
10
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
10
Standard of Care
10
Nivolumab
10
Triptorelin Pamoate
9
Carboplatin
9
pembrolizumab
8
niraparib
8
bicalutamide
8
olaparib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Psychiatric Nursing
×
90 days
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled